Chhajed Prashant N, Gehrer Simone, Pandey Kamlesh V, Vaidya Preyas J, Leuppi Joerg D, Tamm Michael, Strobel Werner
Privat Dozent, Department of Pulmonary Medicine, University Hospital Basel , Switzerland .
Assistant Arzt, Department of Pulmonary Medicine, University Hospital Basel , Switzerland .
J Clin Diagn Res. 2016 Sep;10(9):OC06-OC09. doi: 10.7860/JCDR/2016/19911.8514. Epub 2016 Sep 1.
Nocturnal Non-invasive Positive Pressure Ventilation (NPPV) is the treatment of choice in patients with chronic hypercapnic respiratory failure due to hypoventilation. Continuous oxygen saturation measured with a pulse oximeter provides a surrogate measure of arterial oxygen saturation but does not completely reflect ventilation. Currently, Partial Pressure of Arterial (PaCO2) measured by arterial blood analysis is used for estimating the adequacy of ventilatory support and serves as the gold standard.
To examine the safety, feasibility and utility of cutaneous capnography to re-titrate the non-invasive positive pressure ventilation settings in patients with chronic hypercapnic respiratory failure due to hypoventilation.
Twelve patients with chronic hypercapnic respiratory failure prospectively underwent complete polysomnography and cutaneous capnography measurement on the ear lobe. Non-invasive ventilation pressures were adjusted with the aim of normalizing cutaneous carbon dioxide or at least reducing it by 10 to 15 mmHg. Sensor drift for cutaneous carbon dioxide of 0.7 mmHg per hour was integrated in the analysis.
Mean baseline cutaneous carbon dioxide was 45.4 ± 6.5 mmHg and drift corrected awake value was 45.1 ± 8.3 mmHg. The correlation of baseline cutaneous carbon dioxide and the corrected awake cutaneous carbon dioxide with arterial blood gas values were 0.91 and 0.85 respectively. Inspiratory positive airway pressures were changed in nine patients (75%) and expiratory positive airway pressures in eight patients (66%). Epworth sleepiness score before and after the study showed no change in five patients, improvement in six patients and deterioration in one patient.
Cutaneous capnography is feasible and permits the optimization of non-invasive ventilation pressure settings in patients with chronic hypercapnic respiratory failure due to hypoventilation. Continuous cutaneous capnography might serve as an important additional tool to complement diurnal arterial carbon dioxide tension values.
夜间无创正压通气(NPPV)是因通气不足导致慢性高碳酸血症呼吸衰竭患者的首选治疗方法。通过脉搏血氧仪测量的持续血氧饱和度可提供动脉血氧饱和度的替代指标,但不能完全反映通气情况。目前,通过动脉血分析测量的动脉二氧化碳分压(PaCO2)用于评估通气支持的充分性,并作为金标准。
探讨经皮二氧化碳监测在重新调整因通气不足导致慢性高碳酸血症呼吸衰竭患者无创正压通气设置中的安全性、可行性和实用性。
12例慢性高碳酸血症呼吸衰竭患者前瞻性地接受了完整的多导睡眠图检查和耳垂经皮二氧化碳监测。调整无创通气压力,目标是使经皮二氧化碳正常化或至少降低10至15 mmHg。分析中纳入了每小时0.7 mmHg的经皮二氧化碳传感器漂移。
平均基线经皮二氧化碳为45.4±6.5 mmHg,清醒时漂移校正值为45.1±8.3 mmHg。基线经皮二氧化碳和校正后的清醒经皮二氧化碳与动脉血气值的相关性分别为0.91和0.85。9例患者(75%)改变了吸气气道正压,8例患者(66%)改变了呼气气道正压。研究前后的Epworth嗜睡评分显示,5例患者无变化,6例患者改善,1例患者恶化。
经皮二氧化碳监测是可行的,并且可以优化因通气不足导致慢性高碳酸血症呼吸衰竭患者的无创通气压力设置。持续经皮二氧化碳监测可能是补充日间动脉二氧化碳分压值的重要辅助工具。